Top stories

“Blatant Lies…”: Centre On 7 “Myths” About Its Covid Vaccination Policy

India recorded round 2.11 lakh new COVID-19 circumstances in 24 hours (File)

New Delhi:

The centre – beneath hearth for a Covid vaccination coverage that has seen states frantically red-flag a scarcity of doses amid a lethal second wave – hit again Thursday at “distorted statements, half-truths and blatant lies” which have given rise to “myths” about its administration of the disaster.

In a press release titled “Myths and Facts on India’s Vaccination Process”, the centre responded with seven “facts” to counter claims it had deserted states, will not be working to extend manufacturing (or approve extra manufacturers) of vaccines, and isn’t involved about vaccinating kids.

Among the refuted claims was one which mentioned the centre will not be doing sufficient to approve vaccines obtainable in different nations, together with these already accepted by the WHO.

In response the centre mentioned it’s working with US pharma big Pfizer for the “earliest possible import” of its product, and has already approved Russia’s Sputnik V vaccine.

“… buying vaccines internationally is not similar to buying ‘off the shelf’. Vaccines are in limited supply globally and companies have their own priorities… They also give preference to countries of their origin just as our own vaccine-makers did,” Dr VK Paul, Member (Health) NITI Aayog, mentioned.

Sources informed information company PTI Wednesday that Pfizer and the centre are in talks to fast-track approval of its vaccine. However, the demand for authorized indemnity is proving a stumbling block.

Pfizer informed the centre its vaccine has been accepted for youngsters over 12 – one thing not one of the vaccines in use in India now are cleared, and one other of the “myths” the centre listed. 

Delhi Chief Minister Arvind Kejriwal has asked the centre to approve the Pfizer vaccine for children however Dr Paul urged restraint, declaring the WHO has no advice on vaccinating youngsters.

“… vaccinating kids shouldn’t be determined as a result of some politicians wish to play politics… must be a decision taken after adequate trial data is available,” Dr Paul mentioned within the centre’s reply.

The centre additionally slammed states criticising its “liberalised” vaccination coverage, beneath which states should buy 50 per cent of required doses immediately from producers.

This was cleared after states petitioned the centre to purchase doses on their very own. However, Delhi and Punjab bumped into roadblocks, after Pfizer and Moderna said they would only deal with the centre.

“The truth global tenders have not given any results reaffirm what we now have been saying… vaccines are in brief provide on the planet and it’s not simple to acquire them at quick discover,” Dr Paul mentioned.

The centre countered claims it’s not doing sufficient to extend home manufacturing, saying it’s working as “an effective facilitator”. Earlier this month a prime authorities advisor mentioned over 200 crore doses could be available in India by December.

There was criticism for “some leaders” – no names had been taken – who’re vocal about the lack of doses.

India has been battered by a devastating second wave of infections that has seen whole deaths cross the three lakh mark and lively circumstances hit a report excessive of almost 40 lakh on May 14.

There has been a gentle lower since – this morning round 2.11 lakh cases were recorded in the past 24 hours. The decline is sweet information however consultants say the centre should prep for the third wave.

Read the complete doc right here:

Myths and Facts on India’s Vaccination Process by NDTV on Scribd

Please Donate To Help Those Hit Worst By Covid-19


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker